Adze Biotechnology Inc

Form D Filings

Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
2/19/2025 Equity $0 $6,149,998 $15,000,000 $8,850,002 3/10/2023 2/19/2025 D/A 000178750825000001
2/22/2024 Equity $0 $6,149,998 $15,000,000 $8,850,002 3/10/2023 2/19/2024 D/A 000178750824000001
3/14/2023 Equity $6,149,998 $6,149,998 $15,000,000 $8,850,002 3/10/2023 3/14/2023 D 000178750823000001
5/19/2022 Equity, Debt, Security to be Acquired $1,130,000 $3,687,500 $3,687,500 $0 12/12/2019 5/19/2022 D/A 000178750822000001
11/19/2021 Equity, Debt, Security to be Acquired $557,500 $2,557,500 $4,057,500 $1,500,000 12/12/2019 11/18/2021 D/A 000178750821000002
3/31/2021 Equity, Debt, Security to be Acquired $0 $2,000,000 $3,500,000 $1,500,000 12/12/2019 3/31/2021 D/A 000178750821000001
12/14/2020 Equity, Debt, Security to be Acquired $1,000,000 $2,000,000 $3,500,000 $1,500,000 12/12/2019 12/14/2020 D/A 000178750820000001
12/19/2019 Equity, Debt, Security to be Acquired $1,000,000 $1,000,000 $3,500,000 $2,500,000 12/19/2019 12/19/2019 D/A 000178750819000002
9/9/2019 Equity, Debt, Security to be Acquired $0 $0 $3,000,000 $3,000,000 9/9/2019 D 000178750819000001